Calydon Capital Takes $1.65 Million Position in Humana Inc. $HUM

Calydon Capital bought a new position in shares of Humana Inc. (NYSE:HUM) during the third quarter, according to its most recent filing with the SEC. The fund bought 6,344 shares of the insurance provider’s stock, valued at approximately $1,651,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Illinois Municipal Retirement Fund raised its position in Humana by 9.6% in the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock worth $12,920,000 after acquiring an additional 4,351 shares during the period. Bank of New York Mellon Corp grew its position in shares of Humana by 161.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after acquiring an additional 1,060,767 shares during the period. National Pension Service increased its stake in shares of Humana by 2.8% during the 3rd quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock worth $49,328,000 after purchasing an additional 5,150 shares during the last quarter. Tejara Capital Ltd purchased a new stake in shares of Humana during the 3rd quarter worth approximately $1,873,000. Finally, AMG National Trust Bank raised its holdings in shares of Humana by 106.5% in the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after purchasing an additional 8,744 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Sanjay K. Shetty bought 810 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider directly owned 11,657 shares in the company, valued at $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

HUM has been the topic of several research analyst reports. Barclays dropped their price objective on Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 24th. Oppenheimer set a $250.00 target price on Humana in a research note on Thursday, February 12th. Jefferies Financial Group dropped their price target on Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Thursday, January 22nd. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $225.48.

Humana Stock Up 1.0%

Humana stock opened at $165.38 on Friday. The firm has a 50 day simple moving average of $212.90 and a 200 day simple moving average of $247.87. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana Inc. has a 1-year low of $163.60 and a 1-year high of $315.35. The firm has a market capitalization of $19.85 billion, a price-to-earnings ratio of 16.84, a P/E/G ratio of 1.77 and a beta of 0.44.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. During the same quarter in the prior year, the business posted ($2.16) earnings per share. The business’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a yield of 2.1%. Humana’s dividend payout ratio is 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.